As AI enters the operating room, reports arise of botched surgeries
reuters.com
February 9, 2026
13 min read
Summary
Johnson & Johnson's Acclarent added AI capabilities to its TruDi Navigation System for chronic sinusitis surgeries, utilizing a machine-learning algorithm to assist specialists. Reports have emerged of botched surgeries and misidentified body parts associated with this technology.
Key Takeaways
- Since the integration of AI into the TruDi Navigation System, the FDA has received unconfirmed reports of at least 100 malfunctions and adverse events, including at least 10 injuries from 2021 to 2025.
- Reports indicate that the TruDi system misinformed surgeons about instrument locations during operations, leading to serious incidents such as cerebrospinal fluid leaks and strokes.
- The FDA has authorized at least 1,357 medical devices using AI, which is double the number authorized through 2022, and many of these devices have been linked to product recalls shortly after approval.
- The FDA is struggling to keep pace with the increasing number of AI-enhanced medical devices seeking approval due to staffing challenges.
Community Sentiment
NegativeConcerns
- The article raises concerns about botched surgeries, suggesting that AI may increase the error rate compared to traditional methods, which is alarming for patient safety.
- There is frustration over the article's lack of clarity, as it conflates different types of AI technologies, potentially misleading readers about their implications in medical settings.
- Comments indicate skepticism about the portrayal of AI's role in surgeries, suggesting that the narrative may be sensationalized without sufficient context on actual performance metrics.
Source
reuters.com
Published
February 9, 2026
Reading Time
13 minutes
Relevance Score
46/100
🔥🔥🔥🔥🔥
Why It Matters
This page is optimized for focused reading: quick context up top, a clean summary block, and a direct path to the original source when you want the full story.